Stryker Confident in Orthopedics’ Ability to Bounce Back from COVID-19

Stryker Mako robotic system

Stryker reported 1Q20 orthopedic revenue of USD $1,793.7 million, -2.9% vs. 1Q19. The company’s orthopedic business suffered only modest impact from COVID-19 in the first quarter. Knee sales, particularly in the U.S., held up well compared to competitors as Stryker continued to take market share on the strength of Mako and cementless...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us